San Francisco, California
London, United Kingdom
Nature’s Fingerprint®/MIT LLC takes advantage of natural-abundance stable isotopes for product authentication and process-patent protection of biopharmaceutical intellectual property. We use mass spectrometry to precisely and reproducibly measure stable-isotope ratios to trace product origins and identities as well as the chemical pathways that produce the product.
At this Clubhouse event, John Jasper, PhD, CSO of Nature's Fingerprint® will share the story of the achievements of his company and some of the business challenges he faces as he builds his enterprise. A question of ongoing interest is how to optimize connecting with the business-need ‘deciders’ within potential client companies (e.g., Intellectual Property Directors, Senior Analytical Chemists) when there is rarely a single individual who understands both isotope chemistry and patent law. Another interesting topic is how to apply this high-end technology beyond biopharmaceuticals into surprising areas such as agriculture or food production.
About John Jasper:
Dr. Jasper is the Chief Scientific Officer of Nature’s Fingerprint®/MIT LLC of Niantic, Connecticut. He received his B.A. in Geophysical Sciences and Biological Sciences from The University of Chicago and his Ph.D. from the Massachusetts Institute of Technology / Woods Hole Oceanographic Institution in marine organic- and isotopic chemistry in 1988. He was a Postdoctoral Fellow and Scientist at the Department of Chemistry at Indiana University at Bloomington from 1988-1994 where he employed the newly-developed gas chromatograph / isotope-ratio mass spectrometer (GC-IRMS) in organic- and stable-isotopic isotopic paleochemical research. He has spent the last 20 years in the pharmaceutical industry in three firms: Pfizer / Cultor, Drumbeat Dimensions Inc., a pharmaceutical advisory firm, and at Nature’s Fingerprint®/MIT LLC where he has developed the use of natural-abundance stable isotopes as tracers of Product and Process Authentication. His work in Process Patent Protection, now public since 2012, has already been confidentially used in the pharmaceutical industry to extend the effective patent lives of pharmaceuticals since 2008.
When & Where
CURE is the bioscience cluster of Connecticut, a diverse network of small and large life and health care sciences companies, universities, scientists, educators, students, entrepreneurs, mentors, business experts, and investors. Together we cultivate entrepreneurship, build bioscience companies, and collaborate to ensure a sustainable, high-value bioscience and healthcare community that improves our quality of life and keeps the Connecticut economy strong.